Healthcare cybersecurity vendor selection now hinges on enforcement

At a glance

What this is: This comparison of healthcare cybersecurity vendors says the market is converging on visibility, enforcement, and identity-based architectures, with the biggest gap often sitting between discovery and real-time policy control.

Why it matters: For IAM, PAM, and NHI practitioners, the article reinforces that healthcare security failures are increasingly governed by how identities, devices, and network policy are linked into one enforcement model.

By the numbers:

• Healthcare data breaches now cost an average of $7.42 million per incident, making healthcare the costliest sector for breaches 14 years running.
• The HHS Office for Civil Rights reports a 239% increase in hacking-related breaches over the past five years.
• 72% of healthcare facilities now report disruptions to patient care during cyber incidents.
• In-hospital mortality increases 34-38% during active ransomware attacks.

👉 Read Elisity's comparison of top healthcare cybersecurity vendors for 2026

Context

Healthcare cybersecurity is no longer just about blocking malware or spotting vulnerable devices. The operational problem is that hospitals run tens of thousands of connected assets across IT, IoMT, OT, and identity-driven access paths, so discovery without enforcement leaves a large attack surface in place.

The article frames the central governance gap correctly: teams can often see what is on the network, but cannot always enforce segmentation or access policy quickly enough to matter. That matters to identity programmes because in healthcare, device trust, user trust, and service access are tightly linked, and weak control over one layer weakens the others.

Key questions

Q: How should healthcare security teams close the gap between visibility and enforcement?

A: They should require every discovery control to map to a containment action, such as segmentation, quarantine, or access revocation. In healthcare, seeing a vulnerable device is not enough if the network cannot stop unsafe communication. The goal is to shorten the path from detection to control so that patient-facing workflows stay intact while risky paths are isolated.

Q: Why do IoMT environments need identity-based policy instead of network-only controls?

A: Because medical devices, clinicians, and service accounts all participate in the same operational flows, and network location alone does not explain trust. Identity-based policy lets teams decide what should connect based on asset identity and role, not just IP address. That is essential when devices are unmanaged, embedded, or spread across flat clinical networks.

Q: What do security teams get wrong when they treat device discovery as the end goal?

A: They confuse inventory with governance. Discovery tells you what exists, but governance requires the ability to constrain behavior, limit lateral movement, and prove that policy is actually enforced. In healthcare, that distinction is critical because a fully discovered network can still be fully exploitable if it remains flat and permissive.

Q: Who is accountable when a healthcare segmentation project fails to stop lateral movement?

A: Accountability usually sits across security, networking, and clinical operations, because the control spans all three. If policy is designed without clinical workflow input, or if enforcement is not tied to operational ownership, the organisation ends up with visibility that cannot protect care delivery. Governance should assign explicit containment responsibility before deployment.

Technical breakdown

Why visibility is not the same as control in healthcare networks

Healthcare environments need passive discovery because many medical devices cannot run agents or tolerate interruption. But discovery only tells you what exists and how it talks. It does not stop lateral movement, prevent unsafe connections, or enforce policy when a device deviates from its expected pattern. The practical gap is between classification and containment: a tool may identify an infusion pump, a nurse workstation, and a PACS server, yet still leave them on the same flat trust plane. Identity-based enforcement matters because device identity and access context determine whether a connection should be allowed at all.

Practical implication: map every visibility control to a real enforcement mechanism, not just an alert feed.

How identity-based microsegmentation changes the control model

Identity-based microsegmentation moves away from static network location and toward policy based on device identity, user context, and observed communication patterns. Instead of trusting an IP range or VLAN, the control evaluates who or what is connecting, from where, and for what purpose. In healthcare, that matters because clinical workflows are dynamic and many endpoints are unmanaged or embedded. The architecture works best when policy is written around business-relevant identities, then enforced at the edge or switch layer without interrupting care. This is a governance shift as much as a technical one, because policy ownership becomes shared across security, networking, and clinical operations.

Practical implication: define segmentation policies in terms of identity and clinical function, then test them against real traffic before rollout.

Why agentless discovery is necessary but incomplete

Agentless discovery is often the only viable way to inspect IoMT and embedded systems, since many cannot accept software agents or frequent changes. It relies on network telemetry, protocol inspection, and behavioural baselining to classify devices and identify anomalies. That makes it excellent for coverage, but it also means the control is observational until paired with something that can block, quarantine, or re-route traffic. In identity terms, this is a classic trust-boundary problem: a discovered asset is not a governed asset until policy attaches to it. The article’s strongest technical point is that healthcare security must connect passive intelligence to active control.

Practical implication: do not treat device discovery as a finished control until it can drive quarantine, segmentation, or access decisions.

Threat narrative

Attacker objective: The objective is to gain durable access to clinical environments, disrupt services, and maximise leverage through patient-safety impact.

1. Entry begins when an attacker reaches a healthcare environment through an exposed or weakly controlled device, workstation, or credentialed path.
2. Escalation follows when flat networks or weak segmentation let the attacker move from one trusted clinical or IT asset to another.
3. Impact occurs when the attacker disrupts patient care, exfiltrates sensitive data, or amplifies ransomware effects across clinical workflows.

NHI Mgmt Group analysis

Visibility without enforcement is the healthcare security debt that keeps compounding. The article is right to separate discovery from action, because most hospital environments can now inventory devices but still struggle to stop unsafe east-west movement. That pattern creates a governance illusion: teams think they have control because they can observe the network. In practice, observation without containment leaves clinical, IoMT, and identity paths exposed. Practitioners should treat visibility as a prerequisite, not an outcome.

Healthcare now has a visibility-to-enforcement gap, and that gap is operational, not theoretical. The market keeps rewarding tools that classify devices, but the harder problem is policy enforcement at the pace of clinical traffic. This is where NHI and identity governance intersect with network security: user identities, service accounts, and device identities all shape who can talk to what. If those identities are not reflected in policy design, segmentation becomes a static diagram instead of a living control. Practitioners should evaluate whether enforcement is tied to identity context or just to network placement.

Identity-based microsegmentation is emerging as the right concept for healthcare, because trust decisions increasingly depend on what the asset is, not where it sits. That concept matters across converged environments where IoMT, EHR, and administrative access coexist. It also aligns with Zero Trust Architecture and the broader shift away from implicit network trust. For identity teams, the lesson is clear: device trust and access trust must be governed together, or attackers will use the weakest layer to move laterally. Practitioners should build policy models that treat identity as the control plane for both access and segmentation.

Healthcare vendor selection is becoming a governance test for integration maturity. The article shows that no single platform closes discovery, enforcement, endpoint, and workflow needs on its own. That is not a product failure so much as an architectural reality in a highly constrained environment. The practical consequence is that security leaders must test interoperability, escalation paths, and response ownership before buying. Practitioners should demand evidence that the stack can move from seeing an issue to enforcing containment without a human bridge at every step.

Regulatory pressure is shifting the buying criteria from monitoring to demonstrated containment. The post references segmentation, compliance alignment, and patient safety together, which is the right framing for this sector. In healthcare, a control that only produces reports cannot satisfy the operational expectation that a compromised device or identity path be isolated quickly. The governance implication is that board-level risk now spans safety, uptime, and identity assurance at once. Practitioners should prioritise solutions that prove containment outcomes, not just visibility metrics.

What this signals

Identity-based microsegmentation is becoming a control for enforcing trust boundaries, not just a network design pattern. Healthcare programmes that can identify devices but not constrain their communication will keep inheriting the same lateral-movement risk. The useful question is no longer whether assets are visible, but whether identity context can drive containment fast enough to matter.

Service account governance still matters even in device-heavy environments. Healthcare teams often focus on IoMT and endpoints, but the policy decisions that bridge clinical systems, EHR integrations, and admin workflows depend on non-human identities as well. The broader lesson is that identity observability, not just device observability, is what makes segmentation durable.

The market is moving toward architectures where discovery, access policy, and enforcement are linked. For healthcare CISOs, that means procurement now has to measure response time, integration depth, and containment outcomes, not just asset counts or dashboard quality.

For practitioners

• Map the visibility-to-enforcement gap Inventory where your current tools can identify devices, users, and service accounts, then document where they can actually block traffic or revoke access. Use that map to identify the first clinical segment that still depends on manual intervention for containment.
• Bind segmentation policy to identity context Write policies around device type, clinical function, user role, and expected communication paths instead of relying on VLANs or address ranges alone. Validate that the policy engine can distinguish managed endpoints, IoMT devices, and privileged service access.
• Test containment against live clinical workflows Run pilot enforcement in a controlled segment and verify that patient monitoring, medication systems, and imaging flows continue to function while unsafe connections are blocked. Confirm that the control can operate without creating new downtime pathways.
• Require integration evidence before procurement Ask vendors to demonstrate bidirectional integration with SIEM, CMMS, EHR, and network enforcement layers, then verify how alerts become containment actions. Use the demonstration to confirm who owns escalation when a device or identity path becomes risky.

Key takeaways

• Healthcare cybersecurity now hinges on whether teams can enforce segmentation, not merely see devices.
• The strongest warning sign is the gap between discovery and containment, especially in flat clinical networks.
• Identity context should shape policy for devices, users, and service accounts if organisations want real blast-radius reduction.

Key terms

• Identity-based microsegmentation: A segmentation approach that applies policy based on the identity of a device, user, or workload rather than only its network location. In healthcare, it helps constrain lateral movement by tying trust decisions to asset role and context, which is more durable than flat network zoning.
• Visibility-to-enforcement gap: The difference between knowing an asset exists and being able to stop it from communicating in unsafe ways. In practice, this gap appears when discovery tools produce inventory and risk scores, but the organisation still lacks a fast, reliable mechanism to quarantine, block, or segment.
• Agentless discovery: A method of identifying devices and observing behavior without installing software on the asset itself. It is essential for many IoMT and embedded systems, but it remains observational unless paired with policy enforcement that can change network access or contain suspicious activity.
• Clinical workflow impact: The operational effect a security control has on patient care processes such as telemetry, medication delivery, or imaging. In healthcare security, a control is only practical if it reduces risk without introducing unacceptable delays or outages in clinical operations.

What's in the full article

Elisity's full post covers the operational detail this analysis intentionally leaves for the source:

• Per-vendor capability comparisons for IoMT discovery depth, enforcement design, and workflow impact.
• Detailed notes on which healthcare environments fit agentless visibility versus active segmentation approaches.
• Vendor-specific implementation considerations for integrating discovery with EHR, CMMS, SIEM, and network control layers.
• The article's scoring criteria and category breakdown for evaluating healthcare cybersecurity tools in 2026.

👉 Elisity's full article details the vendor-by-vendor evaluation criteria, category rankings, and architecture trade-offs.

Deepen your knowledge

The NHI Foundation Level course, the industry's only accredited NHI security programme, covers NHI governance, machine identity security, and secrets management. It gives security and identity practitioners a common model for reducing access risk across modern environments.